GGG vs JAZZ · P/E 24, rev $2.24B vs P/E 1988, rev $2.28B
Graco Inc (GGG) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Graco Inc (GGG) is a specialty industrial machinery company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported GGG revenue for 2025-12-26 was $2.24B. Net income was $521.8M. GGG currently screens at market cap $12.25B and trailing P/E 24.1.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
GGG currently screens at market cap $12.25B and trailing P/E 24.1. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the GGG and JAZZ stock pages for the full models.
Not investment advice.